Tenascin-C in primary Merkel cell carcinoma

Journal of Clinical Pathology

Volumn 58, Issue 3, 2005, Pages 297-300

  Koljonen, V ^a,b   Jahkola, T ^b   Tukiainen, E ^b   Granroth, G ^d   Haglund, C ^b   Bohling T ^c  

^a Toolo Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Dept of Pathol Vaasa Ctrl Hosp ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; GLYCOPROTEIN; TENASCIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MERKEL CELL TUMOR; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME; CELL DIVISION; CLINICAL TRIAL; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SKIN TUMOR;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; CELL DIVISION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; SKIN NEOPLASMS; TENASCIN; TUMOR MARKERS, BIOLOGICAL;

EID: 15044341002     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.018432     Document Type: Article

References (33)

1. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development 1993;117:1183-98.
2. Brown JC, Timpl R. The collagen superfamily. Int Arch Allergy Immunol 1995;107:484-90.
3. Hynes RO. Fibronectins. Sci Am 1986;254:42-51.
4. Inaguma Y, Kusakabe M, Mackie EJ, et al. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol 1988;128:245-55.
5. Tanaka K, Hiraiwa N, Hashimoto H, et al. Tenascin-C regulates angiogenesis in tumors through the regulation of vascular endothelial growth factor expression. Int J Cancer 2004;108:31-40.
6. o Schenk S, Chiquet-Ehrismann R. Tenascins. Methods Enzymol 1994;245:52-61.
7. Bourdon MA, Wikstrand CJ, Furthmayr H, et al. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983;43:2796-805.
8. Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989;5:71-92.
9. Latijnhouwers MA, Pfundt R, de Jongh GJ, et al. Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol 1998;17:305-16.
10. Natali PG, Nicotra MR, Bigotti A, et al. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer 1991;47:811-16.
11. Pilch H, Schaffer U, Schlenger K, et al. Expression of tenascin in human cervical cancer-association of tenascin expression with clinicopathological parameters. Gynecol Oncol 1999;73:415-21.
12. Goepel C, Stoerer S, Koelbl H. Tenascin in preinvasive lesions of the vulva and vulvar cancer. Anticancer Res 2003;23:4587-91.
13. Kilic T, Bayri Y, Ozduman K, et al. Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 2002;51:183-92, discussion 192-3.
14. Herold-Mende C, Mueller MM, Bonsanto MM, et al. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 2002;98:362-9.
15. Jahkola T, Toivonen T, von Smitten K, et al. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 1996;69:445-7.
16. Wiksten JP, Lundin J, Nordling S, et al. Tenascin-C expression correlates with prognosis in gastric cancer. Oncology 2003;64:245-50.
17. Jahkola T, Toivonen T, Virtanen I, et al. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 1998;78:1507-13.
18. Ishihara A, Yoshida T, Tamaki H, et al. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1995;1:1035-41.
19. Sakakura T, Kusakabe M. Can tenascin be redundant in cancer development? Perspect Dev Neurobiol 1994;2:111-16.
20. Sugawara I, Hirakoshi J, Masunaga A, et al. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis. Invasion Metastasis 1991;11:325-31.
21. Atula T, Hedstrom J, Finne P, et al. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res 2003;23:3051-6.
22. Chuang TY, Su WP, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol 1990;23(2 Pt 1):254-6.
23. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999;21:16-20.
24. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 2000;31:58-62.
25. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315-23.
26. Koljonen V, Bohling T, Granhroth G, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003;29:607-10.
27. Ortiz-Rey JA, Suarez-Penaranda JM, Da Silva EA, et al. Immunonistochemical detection of fibronectin and tenascin in incised human skin injuries. Forensic Sci Int 2002;126:118-22.
28. Schalkwijk J, Steijlen PM, van Vlijmen-Willems IM, et al. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991;139:1143-50.
29. Sethi T, Rintoul RC, Moore SM, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptasis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-8.
30. Jahkola T, Toivonen T, Nordling S, et al. Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 1998;34:1687-92.
31. Koljonen V, Tukiainen E, Haglund C, et al. Expression of cyclin A in Merkel cell carcinoma. APMIS 2004;112:39-44.
32. Kim CH, Bak KH, Kim YS, et al. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 2000;54:235-40.
33. Schalkwijk J, Van Vlijmen I, Oosterling B, et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991;124:13-20.